Form 8-K - Current report:
SEC Accession No. 0001821586-25-000021
Filing Date
2025-11-05
Accepted
2025-11-05 07:00:58
Documents
13
Period of Report
2025-11-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnlk-20251105.htm   iXBRL 8-K 28371
2 EX-99.1 moonlake-pressreleasexq320.htm EX-99.1 120259
  Complete submission text file 0001821586-25-000021.txt   282047

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mnlk-20251105.xsd EX-101.SCH 1779
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mnlk-20251105_lab.xml EX-101.LAB 21801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mnlk-20251105_pre.xml EX-101.PRE 12482
15 EXTRACTED XBRL INSTANCE DOCUMENT mnlk-20251105_htm.xml XML 2704
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 251451696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)